CT scan for lung infection caused by Mucorales fungus
Part of Infections clinical trials.
This trial looks at CT scan results to see if they can help predict how someone with a serious lung infection caused by Mucorales fungus will do. It asks whether certain features on CT scans can give clues about recovery and future health.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older
- You must have been treated at Strasbourg University Hospital between 2009 and June 2025
- You must have a confirmed lung infection with Mucorales fungus (called pulmonary mucormycosis)
- You must have had at least one CT scan of your chest as part of your care
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests antifungal drugs in people with a rare but serious fungal infection in the lungs called mucormycosis. It aims to find which treatment works best and is safest for patients.
This study looks for specific lab “biomarkers” in people with mucormycosis, a serious fungal infection. It compares results with people who have higher infection risk but no active infection, to help doctors diagnose and track this illness more accurately.
This study looks at how CT scan findings in the chest (mediastinum) can relate to outcomes for people with blood cancers who have mediastinal mass syndrome. It may help doctors better understand which scan features matter most when deciding care in the ICU.
This study uses lung CT scans and bronchoscopy images to quickly find the germs causing severe pneumonia. It may help doctors choose better treatments faster.
This trial tests a new PET scan that uses a special marker to see if you have an invasive fungal infection. It may help doctors better diagnose and treat these infections.
This trial is looking for people who have had a chest CT scan in the past few years. It aims to develop better ways to detect early lung problems and airway changes.
Hear when a new Pulmonary Mucormycosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.